Polish scientists determined plasma CCR2 levels in 100 patients with breast cancer (BC) and controls that involved 35 patients with benign breast tumors and 35 healthy women, as many cancer cells may express chemokines and chemokine receptors. Here, CCR2 is linked to breast carcinoma.